This inventor holds 1 USPTO granted patent. Top assignees: Nanocarrier Co., Ltd., National Cancer Center, Riken Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2018
Title: Yoshikatsu Koga: Innovator in Monoclonal Antibodies
Introduction: Yoshikatsu Koga is a prominent inventor based in Kashiwa, Japan, recognized for his significant contributions to the field of biotechnology. With a focus on therapeutic advancements, he holds one noteworthy patent that has implications for cancer treatment. His work is particularly centered around monoclonal antibodies and their applications in medical science.
Latest Patents: Yoshikatsu Koga's patent, titled "Anti-tissue factor monoclonal antibody," encompasses monoclonal antibodies against both human and mouse tissue factor, as well as the fragments derived from them. This innovation includes pharmaceutical compositions and drug delivery systems that utilize these antibodies. Moreover, the patent outlines various therapeutic methods that leverage these advancements, making a substantial impact on treatment protocols for cancer and other related diseases.
Career Highlights: Koga has an impressive career that reflects his dedication to medical research and innovation. He has worked with esteemed institutions such as the National Cancer Center and The University of Tokyo. His roles at these organizations have allowed him to contribute significantly to the scientific community, focusing on cancer treatment and therapeutic development.
Collaborations: Throughout his career, Yoshikatsu Koga has collaborated with notable colleagues, including Yasuhiro Matsumura and Masahiro Yasunaga. These partnerships have enriched his research efforts and fostered a collaborative environment aimed at addressing complex medical challenges.
Conclusion: Yoshikatsu Koga's contributions to the field of biotechnology, particularly through his patent for an anti-tissue factor monoclonal antibody, showcase his commitment to improving therapeutic approaches in medicine. His collaborations and affiliations with leading institutions highlight the significance of teamwork in driving innovation forward. Koga continues to be a pivotal figure in the quest for effective cancer treatments, making him an important inventor in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile